Refresh

LINCOLN PHARMACEUTICALS LTD. - LPL - R&D has developed an Extended Release Oral Suspension (Cough Syrup) brand name is NAMCOLD- DX(First Time In India)


Download
13 Aug 2015
Lincoln Pharmaceuticals Ltd, vide its letter dated August 12, 2015, has informed BSE about a Company Note titled "LPL - R&D has developed an Extended Release Oral Suspension (Cough Syrup) brand name is NAMCOLD- DX(First Time In India)".

Source: BSE India

View all announcements for LINCOLN PHARMACEUTICALS LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com